Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy-Reference-Cited by-同舟云学术

Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy

Published:2011-03-08 Issue:12 Volume:26 Page:3987-3992
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Roccatello D.,Sciascia S.,Rossi D.,Alpa M.,Naretto C.,Baldovino S.,Menegatti E.,La Grotta R.,Modena V.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/26/12/3987/7632275/gfr109.pdf

Reference36 articles.

1. B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab

2. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients

3. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus

4. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment

5. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Might maintenance therapy be discontinued once clinical remission is achieved in ANCA-associated vasculitis?;Autoimmunity Reviews;2023-08

2. Advances in natural products and antibody drugs for SLE: new therapeutic ideas;Frontiers in Pharmacology;2023-07-10

3. Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management;Drugs;2023-02

4. Daratumumab monotherapy for refractory lupus nephritis;2023-01-19

5. Efficacy and Safety of Rituximab Therapy for Lupus Nephritis Among SLE Female Patients; a Retrospective Hospital-Based Study;Open Access Rheumatology: Research and Reviews;2022-12